ArticleJournal of the Endocrine Society2026
Longer sleep duration and the incidence and progression of diabetic nephropathy: a prospective cohort study.
Article in Journal of the Endocrine Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Sleep duration has been linked to adverse health outcomes, but its association with diabetic nephropathy remains unclear. Objective: This study aimed to assess the association between sleep duration and a composite endpoint of incidence and progression of diabetic nephropathy. Methods: The study participants were 678 Japanese outpatients with type 2 diabetes. Lifestyle habits were assessed at baseline and at years 2 and/or 5. Mean values of lifestyle factors were calculated by averaging measurements from baseline to the date of endpoint onset or the end of follow-up. A multivariable Cox proportional hazards model was used. Results: During a follow-up of 6.0 ± 2.7 years, 215 participants experienced the endpoint. Among lifestyle factors, mean sleep duration was the only factor associated with the endpoint. Compared with participants sleeping <6 hours, the multivariable-adjusted hazard ratios for mean sleep duration of 6 to <7, 7 to <8, and ≥8 hours were 1.08 (95% CI, 0.74-1.57), 1.56 (95% CI, 1.05-2.31), and 1.92 (95% CI, 1.15-3.19), respectively ( Conclusion: Longer, but not shorter, sleep duration is associated with an increased risk of incidence and progression of diabetic nephropathy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.